Duo Therapy Ups Prostate Cancer Survival
Posted on: Tuesday, 13 March 2007, 15:00 CDT
Treating aggressive, non-metastatic prostate cancer with surgery and radiation doubles survival time, according to U.S. researchers.
In a review of the medical records of 453 men with clinically localized, aggressive prostate cancer at the Detroit-based Henry Ford Health System, researchers found that men who were treated conservatively lived an average of just under seven years, while those treated with removal of the prostate and radiation lived an average of 14 years.
The team, led by Ashutosh Tewari, professor of urologic oncology at Weill Cornell Medical College and Mani Menon of the Henry Ford Health System, noted that most patients with aggressive prostate cancer that had not spread outside the prostate were told that their disease was untreatable and that watch and wait was the best approach.
Unfortunately, pessimism abounds among many doctors, said Tewari. This new study points to the fallacy of this outlook.
A report on the research was published in the March issue of the Journal of Urology.
Source: United Press International
Related Articles
- Link Between Sexual Infection And Risk Of Aggressive Prostate Cancer
- Predicting The Return Of Prostate Cancer
- Radiation Helps Prostate Cancer Outcome
- Gene Linked to Aggressive Prostate Cancer
- Cesium-131 Radioactive Isotope Seed From IsoRay Medical Spotlighted at 48th Annual AAPM Meeting; Breakthrough Offers Aggressive New Option for Treatment of Prostate Cancer
- No Link Between Diabetes, Aggressive Prostate Cancer
- New Cesium-131 Radioactive Isotope Seed From IsoRay Medical, Inc. Offers Aggressive Option for Treatment Of Prostate Cancer; FDA Approved for Other Malignant Cancers
- Boffins Take on Prostate Cancer
- Epigenomics Achieves Key Milestone in Development of Prostate Cancer Classification Test
- Trim Down to Fight Prostate Cancer
 |
 |
User Comments (0)
RSS Feeds